Skip to content

South Asian Women & Yoga Education Study

Yoga for Post-menopausal South Asian Women at Risk for Cardiovascular Disease: A Randomized Control Pilot Study

Status
UNKNOWN
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01667835
Acronym
SAWYES
Enrollment
50
Registered
2012-08-17
Start date
2012-11-30
Completion date
2015-08-31
Last updated
2012-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Disease

Keywords

yoga, postmenopausal, sedentary South Asian women

Brief summary

The purpose of this randomized, control pilot study is to measure the effects of a gentle, 12 week hatha yoga program on post-menopausal, obese, sedentary South Asian women at risk for cardiovascular disease. Hatha yoga is a form of structured physical exercises known as asanas, combined with breathing exercises called pranayama, and relaxation techniques. The yoga intervention consists of 9 different yoga poses (asanas) and 3 different breathing exercises (pranayama) that can be easily replicated and readily performed by individuals who are middle-aged and older, overweight, unfit, or who suffer from a chronic illness.

Interventions

BEHAVIORALYoga Intervention

12 week 90 minute hatha yoga session offered three (3x) per week. Hatha yoga is a form of structured physical exercises known as asanas, combined with breathing exercises called pranayama, and relaxation techniques. The yoga intervention consists of 9 different yoga poses (asanas) and 3 different breathing exercises (pranayama) that can be easily replicated and readily performed by individuals who are middle-aged and older, overweight, unfit, or who suffer from a chronic illness.

Sponsors

Kwantlen Polytechnic University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
FEMALE
Age
40 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* 40- 65 years old * Postmenopausal (amenorrhea for ≥ 12 months) * Overweight as evidenced by a body mass index (BMI) ≥ 25 kg/m2), or waist circumference ≥ 80 cm, or have a first degree relative with diabetes or essential hypertension * Sedentary, do not do a regular exercise program (exercising for 20 minutes at sufficient intensity to produce sweating less than 2x/week) * Self-identify as a South Asian (sometimes referred to as East Indian in Canada and may be defined as any person who reports an ethnicity associated with the southern part of Asia or who self-identifies as part of the South Asian visible minority group. This definition encompasses people from a great diversity of ethnic backgrounds, including those with Bangladeshi, Bengali, East Indian, Goan, Gujarati, Hindu, Ismaili, Kashmiri, Nepali, Pakistani, Punjabi, Sikh, Sinhalese, South Asian, Sri Lankan and Tamil ancestry. South Asians may have been born in Canada, on the Indian sub-continent, in the Caribbean, in Africa, in Great Britain or elsewhere * Given consent to research protocol and willingness to be randomized to either the treatment (yoga) or control (no yoga) group.

Exclusion criteria

* Have had a period within the last year * Are not between the ages of 40 and 65 * Have experience with yoga within the last 12 months * Have any serious disease or condition such as diabetes, serious high blood pressure or heart problems, kidney disease, severe asthma, cancer (except for skin cancer that is not melanoma) * Have a major brain or nervous system diagnosis, such as Parkinson's disease or stroke * Have a severe infectious or other medical illness right now such as pneumonia * Use medications to lower blood sugar levels * Have serious back, hip, or neck problems or pain in joints or bones that would prevent the safe completion of a gentle 12 week Hatha yoga program * Regularly use an assistive device (e.g., cane, walker) to walk

Design outcomes

Primary

MeasureTime frameDescription
Change in blood pressurebaseline, at end of study (12 wks), & 3 months post-studyblood pressure is measured as a specific physiologic index of cardiovascular risk.

Secondary

MeasureTime frameDescription
Change in perceived physical well-beingbaseline, end of study (12 wks) & 3 months post-studyPittsburgh Sleep Quality Index, Physical Activity Scale for the Elderly, and Exercise Regularly Scale will be used to measure change in perceived physical well-being
Change in insulin sensitivitybaseline, end of study (12 wks) & 3 months post-studyFasting insulin & glucose will be measured for change in insulin sensitivity as a related index of cardiovascular risk
Change in inflammationbaseline, end of study (12 wks) & 3 months post-studyC-reactive protein will be measured for change in inflammation as a related index of cardiovascular risk
Change in serum total cholesterolbaseline, end of study (12 wks) & 3 months post-studySerum total cholesterol will be measured as a related index of cardiovascular risk
Change in serum high-density lipoprotein (HDL) cholesterolbaseline, end of study (12 wks) & 3 months post-studySerum high-density lipoprotein (HDL) cholesterol will be measured as a related index of cardiovascular risk
Change in serum low-density lipoprotein (LDL) cholesterolbaseline, end of study (12 wks) & 3 months post-studySerum low-density lipoprotein (LDL)cholesterol will be measured as a related index of cardiovascular risk
Change in subjective well-beingbaseline, at end of study (12 wks), & 3 months post-studyThe Perceived Stress Scale and Abbreviated Duke Social Support Index will be used to measure subjective well-being.
Change in waist circumference.baseline, end of study (12 wks) & 3 months post-studyWaist circumference will be measured for change in visceral adiposity as a related index of cardiovascular risk
Change waist-hip ratiobaseline, end of study (12 wks) & 3 months post-studyWaist-hip ratio will be measured for change in visceral adiposity as a related index of cardiovascular risk
Change in body mass index (BMI)baseline, end of study (12 wks) & 3 months post-studyBody mass index (BMI) will be measured for change in visceral adiposity as a related index of cardiovascular risk
Change in resting heart ratebaseline, end of study (12 wks) & 3 months post-studyResting heart rate will be measured for change in sympathetic activity as a related index of cardiovascular risk
Change in heart ratebaseline, at end of study (12 wks), & 3 months post-studyHeart rate will be measured for change in sympathetic activity as a related index of cardiovascular risk
Change in serum triglyceridesbaseline, end of study (12 wks) & 3 months post-studySerum triglycerides will be measured as a related index of cardiovascular risk

Countries

Canada

Contacts

Primary ContactAmandah L Hoogbruin, PhD
amandah.hoogbruin@kwantlen.ca604 599 3144
Backup ContactRaymond Dong, FRCPC
raydongheart@gmail.com604 838 8418

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026